首页> 美国卫生研究院文献>other >Consolidation Strategies in Ovarian Cancer: Observations for Future Clinical Trials

【2h】

Consolidation Strategies in Ovarian Cancer: Observations for Future Clinical Trials

机译：整合战略在卵巢癌：观测在今后的临床试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

PurposeTo describe the characteristics of a series of study populations of ovarian cancer patients with identical elegibility criteria in second or subsequent clinical remission (cCR) and to propose endpoint benchmarks for future consolidation studies.

著录项

期刊名称 other
作者
Paul Sabbatini; David Spriggs; Carol Aghajanian; Martee Hensley; William Tew; Jason Konner; Kathryn Bell-McGuinn; Margrit Juretzka; Alexia Iasonos;
展开▼
作者单位

展开▼
年(卷),期 -1(116),1
年度 -1
页码 016
总页数 14
原文格式 PDF
正文语种
中图分类
关键词
入库时间 2022-08-21 11:29:10

相似文献

外文文献
中文文献
专利

1. Consolidation strategies in ovarian cancer: observations for future clinical trials. [J] . Sabbatini P, Spriggs D, Aghajanian Gynecologic Oncology: An International Journal . 2010,第1期

机译：卵巢癌的巩固策略：对未来临床试验的观察。
2. The Value of Observational Cohort Studies for Cancer DrugsRandomized controlled trials - the gold standard for clinical drug evaluation -can't always predict adverse events in real-world settings. For the new cancer therapies, observational cohort studies (OCSs) can help evaluate their effects in broader populations and provide valuable information for future clinical trials. [J] . DAVID R. SPIGEL Biotechnology healthcare . 2010,第2期

机译：观察性队列研究对癌症药物的价值随机对照试验-临床药物评估的金标准-不能总是预测现实世界中的不良事件。对于新的癌症疗法，观察性队列研究（OCS）可以帮助评估它们在更广泛的人群中的作用，并为将来的临床试验提供有价值的信息。
3. Triple peptide vaccination as consolidation treatment in women affected by ovarian and breast cancer: Clinical and immunological data of a phase I/II clinical trial [J] . Morena Antonilli, Hassan Rahimi, Valeria Visconti, International journal of oncology . 2016,第4期

机译：三肽疫苗接种作为合并治疗的卵巢癌和乳腺癌妇女：I / II期临床试验的临床和免疫学数据
4. Patient-Centered Strategies to Increase Participation in Cancer Clinical Trials [C] . Lynette Hammond Gerido, Zhe He IEEE International Conference on Healthcare Informatics . 2018

机译：以患者为中心的策略以增加癌症临床试验的参与度
5. Understanding strategies that promote minority participation in breast cancer clinical trials. [D] . Lawrence, Briana Monique. 2013

机译：了解促进少数群体参与乳腺癌临床试验的策略。
6. Triple peptide vaccination as consolidation treatment in women affected by ovarian and breast cancer: Clinical and immunological data of a phase I/II clinical trial [O] . MORENA ANTONILLI, HASSAN RAHIMI, VALERIA VISCONTI, -1

机译：三肽疫苗接种作为合并治疗的卵巢癌和乳腺癌妇女：I / II期临床试验的临床和免疫学数据
7. Consolidation strategies in ovarian cancer: Observations for future clinical trials [O] . Paul Sabbatini, David Spriggs, Carol Aghajanian, 2010

机译：卵巢癌的整合策略：未来临床试验的观察

Consolidation Strategies in Ovarian Cancer: Observations for Future Clinical Trials

摘要

著录项

相似文献

相关主题

期刊订阅